Dipyrone-NSAID Hybrids as CB2 Inverse Agonists Endowed with Analgesic Properties

Vol 2, 2022 - 152409
Poster
Favoritar este trabalho
Como citar esse trabalho?
Resumo

Modulation of endocannabinoid system contributes to analgesia, highlighting its promising role on the suppression of neuropathic pain. Recently, arachidonylamides have been identified as cannabinoid receptor ligands, which suggests their potential role on the analgesic activity displayed by dipyrone. Compounds 6-11 were designed by molecular hybridization of non-steroidal anti-inflammatory drugs (2-4) with the major metabolites of dipyrone. All substances were obtained in good yields (50-80%) and presented good drug-like properties, such as aqueous solubility (10-70 μM), lipophilicity (log D7.4 ranging from 1-3), metabolic and chemical stability against pH (2 and 7.4). Compounds 6-11 showed medium to high permeability by PAMPA assay (GIT and BBB). The compounds presented inverse agonist activity for CB2 receptors in vitro (EC50 = 0.36 µM; Emax = 63%). Compound 11 was selected to demonstrate their analgesic activity in the formalin test and the results indicated activity in the inflammatory phase associated with an pain condition.

Compartilhe suas ideias ou dúvidas com os autores!

Sabia que o maior estímulo no desenvolvimento científico e cultural é a curiosidade? Deixe seus questionamentos ou sugestões para o autor!

Faça login para interagir

Tem uma dúvida ou sugestão? Compartilhe seu feedback com os autores!

Instituições
  • 1 Universidade Federal do Rio de Janeiro
Eixo Temático
  • 2. Medicinal Chemistry of Synthetic Compounds
Palavras-chave
Cannabinoid receptors
Pyrazolamides
Molecular Hybridization
Inverse agonist
Analgesics